Microorganisms could regulate immune reactions in intestinal and pulmonary tissues through modulating NLRP3 inflammatory bodies, which then affect intestinal and pulmonary disorders (Donovan et al., 2020). This evidence concerns the gene NLRP3 and lung disorder.